Such as, in triple unfavorable breast cancer (TNBC),25 As well as in hepatocellular carcinoma,26 DNA methylation profiles have helped on the identification of distinctive subgroups with clinical relevance. Epigenetic strategies have also aided to the development of prognostic exams to assess the sensitivity of cancer cells to specific medicine.27 https://directivepublications.org/world-journal-of-clinical-cancer-research/